The global diabetes injection pens market is projected to grow at a CAGR of approximately 7% through 2028. Market expansion ...

People who stop taking GLP-1 drugs such as Ozempic and Wegovy for weight loss are projected to regain their shed pounds ...

WANNABE slimmers were today urged not to suddenly restart fat jabs at the same dose after pressing pause over Christmas.

Participants regained their original weight within an average of 1.7 years after stopping any type of weight loss medication.

CivicaScript®, LLC, a nonprofit company dedicated to bringing low-cost generic medicines and biosimilars to U.S. patients, today announced the availability of two new products: insulin glargine-yfgn ...

Two years ago, I was diagnosed with type 1 diabetes. Though it comes with challenges, I won't let it stop me from doing what ...

Oclaiz is a subcutaneous long-acting octreotid depot, designed for optimized disease control and convenient self-administration. The product is based on Camurus' FluidCrystal technology and is ...

Genuine injections on the market include Mounjaro and Zepbound. The company that produces them, Eli Lilly, previously ...

GLP-1 drugs like Ozempic and Mounjaro have significant health benefits for type 1 diabetes, including weight loss, despite ...

India, Jan. 10 -- 2026 has begun and investors are increasingly looking beyond short-term noise and focusing on businesses riding long structural trends. From data centres and AI infrastructure to ...